1. Biosolv - Biosytes (Goldman) - Q-Gel®
U.S. Patent No. 6,056,971 (Expires July 23, 2017)
2. Enhanced Bioavailablility of CoQ10
U.S. Patent No. 6,300,377 (Raj Chopra) - "Hyrdosolv" (Expires February 22, 2021)
3. Composition of palatable Oral CoQ10 Liquid
U.S. Patent No. 6,441,050 (Raj Chopra) - "Opti-solv" (Expires August 29, 2029)
4. Q-Nol® (Reduced CoQ10)
U.S. Patent No. 6,740,338 (Raj Chopra) - "Q-Nol" (Expires May, 2024)
5. Reduced Form of Coenzyme Q10 in High Bioavailability - stable dosage forms and related applications
Canadian Patent No. 2,397,447 (Raj Chopra) - "Q-Nol" (Expires January 18, 2021)
6. Palatable Oral Coenzyme Q10 Liquid
Canadian Patent No. 2,417,289 (Raj Chopra) - "Q-Nol" (Expires August 17, 2021)
7. HydroQsorb
U.S. Patent No. 6,861,447 (Wacker)
8. LiQsorb
U.S. Patent No. 6,455,072 (3i)
9. Bioslov - Biosytes (Goldman) - Q-Gel®
Canadian Patent No. 2,236,023